Double maintains 7 strategies that include ILMN - Illumina, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PBE | 68.83% | $223.86M | 0.58% |
GNOM | 65.33% | $44.38M | 0.5% |
IBB | 64.72% | $5.28B | 0.45% |
BBH | 64.38% | $329.37M | 0.35% |
FBT | 64.22% | $1.01B | 0.54% |
MOAT | 61.18% | $12.65B | 0.47% |
ARKG | 60.57% | $1.02B | 0.75% |
RSPH | 58.97% | $730.32M | 0.4% |
XBI | 58.56% | $4.84B | 0.35% |
FXH | 58.18% | $899.62M | 0.62% |
XHE | 58.15% | $166.19M | 0.35% |
QQQJ | 58.02% | $618.04M | 0.15% |
SMOT | 57.40% | $386.39M | 0.49% |
XRT | 56.72% | $309.43M | 0.35% |
FIW | 56.63% | $1.86B | 0.51% |
DSTL | 56.50% | $1.78B | 0.39% |
IJJ | 56.40% | $7.69B | 0.18% |
MDY | 56.37% | $22.96B | 0.24% |
SPMD | 56.36% | $13.15B | 0.03% |
NUSC | 56.28% | $1.14B | 0.31% |
SeekingAlpha
The AI Arms Race Heats Up: June's Robotics And Automation Playbook
Yahoo
Explore the future of proteomics where new biomarkers are redefining disease, possibly outpacing genomics. With venture capital backing and double-digit growth, the market forecasts suggest transformative impacts on cancer diagnostics and healthcare costs. Discover key insights and investment prospects today.Dublin, June 30, 2025 (GLOBE NEWSWIRE) -- The "Proteomic Biomarker Analytics Market Forecasts by Application, Technology, Product and Place, with Executive and Consultant Guides" report has
Yahoo
ILMN jumps 2.9% after striking a $350M deal to acquire SomaLogic and boost its fast-growing multiomics strategy.
MarketWatch
Illumina Inc. stock outperforms competitors on strong trading day
Yahoo
Avance Biosciences is proud to announce the launch of its Next-Generation Sequencing (NGS) Center of Excellence, a purpose-built facility designed to unify and enhance the company's sequencing capabilities across all phases of drug development. Located in Houston, the Center delivers comprehensive sequencing services to support research, preclinical and clinical studies, diagnostic support, and GMP-compliant testing for biologics and cell and gene therapies.
Yahoo
Illumina, Inc. (NASDAQ: ILMN) announced it has entered into a definitive agreement with Standard BioTools (NASDAQ: LAB) under which Illumina will acquire SomaLogic, a leader in data-driven proteomics technology, and other specified assets for $350 million in cash payable at closing, subject to customary adjustments, plus up to $75 million in near-term performance-based milestones and performance-based royalties.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -41.80% | $165.58M | 0.85% |
TAIL | -39.85% | $99.49M | 0.59% |
BTAL | -39.54% | $295.67M | 1.43% |
IVOL | -35.54% | $348.25M | 1.02% |
FXY | -25.80% | $820.31M | 0.4% |
XONE | -22.51% | $585.85M | 0.03% |
SPTS | -20.52% | $5.77B | 0.03% |
STPZ | -18.42% | $450.05M | 0.2% |
UTWO | -18.25% | $379.27M | 0.15% |
SCHO | -17.49% | $11.46B | 0.03% |
VTIP | -16.64% | $15.34B | 0.03% |
IBTH | -16.40% | $1.60B | 0.07% |
VGSH | -16.32% | $22.77B | 0.03% |
IBTG | -15.73% | $1.92B | 0.07% |
CLIP | -15.45% | $1.51B | 0.07% |
FTSD | -15.09% | $231.68M | 0.25% |
SHYM | -14.23% | $354.58M | 0.35% |
TBLL | -13.65% | $2.13B | 0.08% |
IBTI | -13.41% | $1.06B | 0.07% |
XHLF | -13.35% | $1.73B | 0.03% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VSA | 0.04% | $8.76M | -18.25% | 0.00% |
PRPO | 0.06% | $16.51M | +118.40% | 0.00% |
MSIF | -0.22% | $756.27M | +33.83% | 7.70% |
K | -0.25% | $27.71B | +40.85% | 2.85% |
AIFU | 0.26% | $6.51B | +93.75% | 0.00% |
PSQH | 0.34% | $97.45M | -38.51% | 0.00% |
AEP | 0.55% | $55.76B | +19.14% | 3.55% |
CCI | 0.64% | $45.17B | +8.85% | 5.55% |
GFI | -0.77% | $21.24B | +58.84% | 2.32% |
VSTA | 0.84% | $341.66M | +42.00% | 0.00% |
STG | 0.97% | $30.47M | -21.87% | 0.00% |
IMDX | 1.06% | $86.94M | +2.70% | 0.00% |
KR | -1.28% | $47.17B | +41.48% | 1.81% |
LITB | 1.29% | $22.07M | -77.41% | 0.00% |
DOCS | -1.36% | $10.97B | +116.54% | 0.00% |
KO | 1.37% | $308.49B | +13.49% | 2.78% |
CL | 1.42% | $74.59B | -4.24% | 2.20% |
MVO | 1.57% | $66.70M | -38.30% | 21.83% |
TMUS | -1.58% | $274.22B | +34.19% | 1.37% |
NGVC | 1.66% | $914.11M | +83.89% | 1.16% |
Current Value
$98.151 Year Return
Current Value
$98.151 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MO | -15.19% | $97.93B | +26.25% | 6.95% |
CBOE | -13.65% | $24.29B | +35.36% | 1.09% |
T | -11.54% | $207.81B | +53.45% | 3.83% |
CME | -10.93% | $99.25B | +39.75% | 3.87% |
ED | -10.49% | $36.31B | +13.27% | 3.35% |
EXC | -9.09% | $43.82B | +25.72% | 3.63% |
TEF | -7.18% | $30.02B | +27.27% | 6.13% |
PM | -6.15% | $276.33B | +74.67% | 3.05% |
TU | -5.47% | $24.83B | +9.19% | 7.12% |
PPC | -5.22% | $10.79B | +32.45% | 0.00% |
DUK | -5.10% | $92.39B | +19.10% | 3.55% |
PULM | -4.38% | $24.14M | +230.50% | 0.00% |
VHC | -3.66% | $48.79M | +87.46% | 0.00% |
MKTX | -3.17% | $8.37B | +15.12% | 1.35% |
BTI | -3.16% | $102.21B | +50.27% | 6.54% |
NEUE | -2.89% | $61.16M | +29.25% | 0.00% |
AQB | -2.75% | $2.87M | -53.40% | 0.00% |
COR | -2.59% | $57.24B | +32.73% | 0.74% |
BTCT | -2.55% | $22.63M | +43.33% | 0.00% |
CREG | -2.49% | $5.66M | -79.19% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
A | 66.09% | $34.22B | -4.24% | 1.01% |
RVTY | 65.79% | $11.67B | -2.92% | 0.28% |
TECH | 65.06% | $8.16B | -26.90% | 0.62% |
BIO | 64.78% | $6.75B | -7.31% | 0.00% |
BRKR | 63.58% | $6.35B | -32.02% | 0.48% |
MTD | 60.71% | $25.05B | -11.18% | 0.00% |
IQV | 58.17% | $28.13B | -21.62% | 0.00% |
TMO | 57.99% | $159.10B | -21.06% | 0.39% |
AVTR | 57.04% | $9.49B | -32.36% | 0.00% |
DHR | 55.77% | $143.92B | -16.35% | 0.59% |
KLIC | 53.96% | $1.88B | -27.34% | 2.28% |
ZBRA | 53.54% | $16.04B | +1.76% | 0.00% |
AZTA | 52.91% | $1.45B | -38.37% | 0.00% |
QGEN | 52.56% | $10.44B | +15.16% | 0.00% |
WAT | 52.44% | $21.25B | +25.50% | 0.00% |
TXG | 51.91% | $1.51B | -36.09% | 0.00% |
MKSI | 51.58% | $6.76B | -24.09% | 0.87% |
BC | 51.11% | $3.80B | -17.04% | 2.91% |
LFUS | 51.01% | $5.71B | -7.97% | 1.21% |
TWST | 50.63% | $2.20B | -22.34% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
MLN | -0.03% | $540.39M | 0.24% |
CARY | -0.16% | $347.36M | 0.8% |
IBD | 0.18% | $384.47M | 0.43% |
TFLO | 0.18% | $6.83B | 0.15% |
IBTP | -0.21% | $143.32M | 0.07% |
IBDQ | -0.37% | $2.99B | 0.1% |
WEAT | 0.37% | $117.67M | 0.28% |
DFIP | 0.42% | $920.81M | 0.11% |
YEAR | -0.52% | $1.47B | 0.25% |
ITM | 0.57% | $1.87B | 0.18% |
CANE | 0.62% | $10.58M | 0.29% |
BSCP | -0.92% | $3.28B | 0.1% |
SCHP | 0.99% | $12.99B | 0.03% |
OWNS | 1.02% | $130.26M | 0.3% |
TDTF | -1.06% | $845.57M | 0.18% |
GTIP | 1.07% | $164.16M | 0.12% |
GSY | 1.09% | $2.86B | 0.22% |
SHYD | -1.12% | $332.28M | 0.35% |
DFNM | 1.13% | $1.57B | 0.17% |
CGSM | 1.26% | $708.96M | 0.25% |